Filter Results :

Your search for Immune returned 156 reports

Sort by


Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021

29 Nov 2016  |  Published by:  MarketsandMarkets
The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth...

$ 5,650.00

Read More

Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

03 Nov 2016  |  Published by:  Technavio-Infiniti Research
About Autoimmune and Inflammatory ImmunomodulatorsImmunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet nee...

$ 2,500.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura). The main objective of this report to track competitor pipelin...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). The main objective of this report to track competitor pipel...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

Primary Immune Deficiency (PID)-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Primary Immune Deficiency (PID)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Primary Immune Deficiency (PID). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-l...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2015,report provides Acquired (Autoimmune) Hemolytic Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The rep...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Immune Check Activators- Competitive Landscape, Technology and Pipeline Analysis, 2016

01 Nov 2016  |  Published by:  DelveInsight
DelveInsight's report deals with the TNFR/TNF superfamily members as agents of Cancer Immunotherapy that have brought a new dawn upon the existing therapies for cancer. Controlling diverse facets of immune function, it has brought into application a technology that rested in the pipeline for years. ...

$ 1,575.00
$ 1,102.50
( Save 30% )

Read More

Global Autoimmune Partnering 2010-2016: Deal trends, players and financials

01 Nov 2016  |  Published by:  CurrentPartnering
Global Autoimmune Partnering 2010 to 2016 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. -Trends in Autoimmune partnering deals -Financial deal terms for headline, upfront and royalty by stage of deve...

$ 2,995.00

Read More

Adimmune/Valneva - Vaccine Production Plant - Taiwan - Construction Project Profile

28 Oct 2016  |  Published by:  Timetric
Synopsis"Adimmune/Valneva - Vaccine Production Plant - Taiwan" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key pr...

$ 75.00

Read More

Global Autoimmune Disorders Treatment Market Research Report 2016

13 Oct 2016  |  Published by:  9Dimen Research
2016 Global Autoimmune Disorders Treatment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Autoimmune Disorders Treatment industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United State...

$ 2,850.00

Read More

Global Autoimmune Disease Diagnostics Market 2017-2021

30 Sep 2016  |  Published by:  Technavio-Infiniti Research
About the Autoimmune Disease Diagnostics Market Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune...

$ 3,500.00

Read More

MedImmune Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

22 Sep 2016  |  Published by:  GlobalData
SummaryMedImmune Limited (MedImmune), a subsidiary of AstraZeneca Plc is a biotechnology company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respiratory syncytial virus. The company's products include s...

$ 250.00

Read More

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

22 Sep 2016  |  Published by:  GlobalData
SummaryNovImmune SA (NovImmune) is a drug discovery and development company that focuses on the discovery and development of antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. Its pipeline products include NI-1801, NI-0401, NI-1701, NI-0501, NI-1401...

$ 250.00

Read More

Neurimmune Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 Sep 2016  |  Published by:  GlobalData
SummaryNeurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG, is a biopharmaceutical company that develops immunotherapeutics for unmet medical needs. Its product pipeline includes human-derived monoclonal antibodies developed for the treatment and prevention of human diso...

$ 250.00

Read More
Total 156 records.